The rate of growth in retail constant value sales of consumer health will slow significantly during 2021 but remain robust. COVID-19 will continue to boost demand for paediatric consumer health – albeit not to same extent as in 2020. Although COVID-19 poses far less of a threat to children than to adults, many parents are still very anxious to reduce the risk of their children contracting the virus, not least because this also helps to protect themselves and older relatives from contracting it.

Euromonitor International’s Paediatric Consumer Health in Turkey report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments , Paediatric Analgesics , Paediatric Cough, Cold and Allergy Remedies , Paediatric Dermatologicals , Paediatric Digestive Remedies , Paediatric Vitamins and Dietary Supplements .

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.